Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 4
2004 7
2005 2
2006 5
2007 7
2008 9
2009 10
2010 8
2011 12
2012 15
2013 16
2014 23
2015 23
2016 34
2017 41
2018 26
2019 32
2020 35
2021 44
2022 51
2023 47
2024 20

Text availability

Article attribute

Article type

Publication date

Search Results

419 results

Results by year

Filters applied: . Clear all
Page 1
Pseudomonas aeruginosa Lipid A Structural Variants Induce Altered Immune Responses.
Hofstaedter CE, O'Keefe IP, Met CM, Wu L, Vanderwoude J, Shin S, Diggle SP, Riquelme SA, Rasko DA, Doi Y, Harro JM, Kopp BT, Ernst RK. Hofstaedter CE, et al. Among authors: doi y. Am J Respir Cell Mol Biol. 2024 Apr 24. doi: 10.1165/rcmb.2024-0059OC. Online ahead of print. Am J Respir Cell Mol Biol. 2024. PMID: 38656811
How Much More Efficient Are Adaptive Platform Trials Than Multiple Stand-Alone Trials? A Comprehensive Simulation Study for Streamlining Drug Development During a Pandemic.
Sasaki M, Sato H, Uemura Y, Mikami A, Ichihara N, Fujitani S, Kondo M, Doi Y, Morino E, Tokita D, Ohmagari N, Sugiura W, Hirakawa A. Sasaki M, et al. Among authors: doi y. Clin Pharmacol Ther. 2024 Mar 5. doi: 10.1002/cpt.3224. Online ahead of print. Clin Pharmacol Ther. 2024. PMID: 38441177
Effects of sodium-glucose co-transporter 2 inhibitors on ultrafiltration in patients with peritoneal dialysis: a protocol for a randomized, double-blind, placebo-controlled, crossover trial (EMPOWERED).
Doi Y, Shinzawa M, Arisato T, Oka H, Matsumoto A, Kitamura H, Nakazono Y, Nishiya Y, Ueda Y, Kamimura T, Hayashi T, Yoshihara F, Isaka Y. Doi Y, et al. Clin Exp Nephrol. 2024 Feb 25. doi: 10.1007/s10157-024-02467-w. Online ahead of print. Clin Exp Nephrol. 2024. PMID: 38402502
419 results